T. A. Damron, Vice-Chairman and David G. Murray Endowed Professor of Orthopedics, Musculoskeletal Science Research Center, Department of Orthopedic Surgery, Institute for Human Performance, SUNY Upstate Medical University, Syracuse, NY, USA
T. A. Damron MD, Musculoskeletal Science Research Center, Institute for Human Performance, 505 Irving Avenue, Room 3117, Syracuse, NY 13210 USA, Email: firstname.lastname@example.org
This CORR Insights is a commentary on the article “What Is the Adverse Event Profile After Prophylactic Treatment of Femoral Shaft or Distal Femur Metastases?” by McLynn and colleagues available at: DOI: 10.1097/CORR.0000000000000489.
The institution of the author (TAD) has received, during the study period, funding from the Orthopaedic Research and Education Foundation, the Musculoskeletal Tumor Society, and the Carol Baldwin Breast Cancer Research Foundation.
All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research® editors and board members are on file with the publication and can be viewed on request.
The opinions expressed are those of the writers, and do not reflect the opinion or policy of CORR® or The Association of Bone and Joint Surgeons®.
Received September 12, 2018
Accepted September 20, 2018